Overview

A class action lawsuit has been filed against agilon health, inc., (“agilon health,” or the “Company”) (NYSE : AGL) and certain of the Company’s current and former senior executive officers alleging violations of federal securities laws. The agilon health lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired agilon health securities between February 26, 2025, and August 4, 2025, both dates inclusive (the “Class Period”). Investors have until March 2, 2026, to seek appointment as lead plaintiff of the agilon health class action lawsuit.

Agilon health, is a healthcare company that partners with independent primary care physician groups to deliver value-based care for seniors, particularly those on Medicare. It provides a unified platform combining technology, capital, analytics, and operational support that enables physician practices to manage the total health needs of their patients.

The lawsuit alleges agilon health made false and/or misleading statements that recklessly overstated the positive impact from “strategic actions” taken by the Company. The lawsuit further alleges that executives at agilon health recklessly overstated the Company’s ability to achieve positive financial results for 2025, in the face of known headwinds. When the true details entered the market, the lawsuit claims that investors suffered damages.

The truth was revealed on August 4, 2025, when agilon health issued a press release entitled  “agilon health Announces Leadership Transition.” The release stated that Defendant Steven Sell was stepping down as President, CEO, and Director of the Board. Additionally, also on August 4, the Company announced disappointing financial results for the second quarter of 2025 and suspended its previously issued guidance for 2025. On this news, the price of agilon health common stock plummeted, falling by more than 50% to close at $0.88 per share on August 5, 2025.

*            *            *

If you purchased or otherwise acquired agilon health securities between February 26, 2025, and August 4, 2025, and you wish to serve as lead plaintiff in this lawsuit, you are encouraged to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt attorneys Brian O’Mara or Hani Farah by calling (888) 287-9005 or at investors@dicellolevitt.com. 

The deadline to apply to the Court to serve as a lead plaintiff in the agilon health lawsuit is March 2, 2026.